Literature DB >> 21478401

An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection.

Danielle N Kroetz1, George S Deepe.   

Abstract

CCR5 is a potent mediator of regulatory T cell (Treg) chemotaxis. In murine histoplasmosis, mice lacking CCR5 or endogenous CCL4 have a reduced number of Tregs in the lungs, which results in accelerated resolution of infection. In this study, we demonstrate that CCR5 controls the outcome of Histoplasma capsulatum infection by dictating thymic and lymph node egress of Tregs. Mice lacking CCR5 or treated with a mAb to CCL4 had more Tregs in the thymus prior to and during infection. Thymic accumulation was associated with diminished transcription of the sphingosine 1-phosphate 1 receptor and Krüppel-like factor 2, both of which regulate thymic and lymph node emigration of T cells. The significance of CCR5 in Treg egress was demonstrated by generating mixed bone marrow chimeras. Chimeric mice had an increased proportion of CCR5(-/-) Tregs in the thymus and lymph nodes and a decreased proportion of Tregs in the lungs prior to and during H. capsulatum infection. Hence, CCR5 signaling regulates pathogen persistence in murine histoplasmosis by regulating Tregs exiting from the thymus and lymph nodes and, consequently, their subsequent homing in the periphery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478401      PMCID: PMC3111447          DOI: 10.4049/jimmunol.1003876

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Phosphatidylinositol 3-kinase regulates thymic exit.

Authors:  Susannah D Barbee; Jose Alberola-Ila
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 2.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Authors:  Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

3.  CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance.

Authors:  Hirotsugu Kurobe; Cunlan Liu; Tomoo Ueno; Fumi Saito; Izumi Ohigashi; Natalie Seach; Rieko Arakaki; Yoshio Hayashi; Tetsuya Kitagawa; Martin Lipp; Richard L Boyd; Yousuke Takahama
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

4.  The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.

Authors:  Elzbieta Sawicka; Gerald Dubois; Gabor Jarai; Matthew Edwards; Matthew Thomas; Andy Nicholls; Rainer Albert; Catherine Newson; Volker Brinkmann; Christoph Walker
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

5.  Kruppel-like factor 2 regulates thymocyte and T-cell migration.

Authors:  Corey M Carlson; Bart T Endrizzi; Jinghai Wu; Xiaojie Ding; Michael A Weinreich; Elizabeth R Walsh; Maqsood A Wani; Jerry B Lingrel; Kristin A Hogquist; Stephen C Jameson
Journal:  Nature       Date:  2006-07-20       Impact factor: 49.962

6.  CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression.

Authors:  Ana Paula Moreira; Karen Angelica Cavassani; Fabrine Sales Massafera Tristão; Ana Paula Campanelli; Roberto Martinez; Marcos Antonio Rossi; João S Silva
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

8.  Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns.

Authors:  Eric Sebzda; Zhiying Zou; John S Lee; Tao Wang; Mark L Kahn
Journal:  Nat Immunol       Date:  2008-02-03       Impact factor: 25.606

9.  Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription.

Authors:  Ailin Bai; Hui Hu; Mandy Yeung; Jianzhu Chen
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.

Authors:  Ekaterina Yurchenko; Michael Tritt; Valerie Hay; Ethan M Shevach; Yasmine Belkaid; Ciriaco A Piccirillo
Journal:  J Exp Med       Date:  2006-10-02       Impact factor: 14.307

View more
  12 in total

1.  CCR5 deficiency mitigates the deleterious effects of tumor necrosis factor α antagonism in murine histoplasmosis.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  J Infect Dis       Date:  2012-01-23       Impact factor: 5.226

2.  Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.

Authors:  E C Halvorsen; M J Hamilton; A Young; B J Wadsworth; N E LePard; H N Lee; N Firmino; J L Collier; K L Bennewith
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

Review 3.  The role of cytokines and chemokines in Histoplasma capsulatum infection.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  Cytokine       Date:  2011-08-26       Impact factor: 3.861

Review 4.  Adaptive immunity to fungi.

Authors:  Marcel Wüthrich; George S Deepe; Bruce Klein
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 5.  Mononuclear phagocyte-mediated antifungal immunity: the role of chemotactic receptors and ligands.

Authors:  Muthulekha Swamydas; Timothy J Break; Michail S Lionakis
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

6.  Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.

Authors:  Max W Richardson; Julie Jadlowsky; Chuka A Didigu; Robert W Doms; James L Riley
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

7.  CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans.

Authors:  Amit Saxena; Marcin Bujak; Olga Frunza; Marcin Dobaczewski; Carlos Gonzalez-Quesada; Bao Lu; Craig Gerard; Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2014-06-01       Impact factor: 10.787

8.  CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.

Authors:  Allison N Seyfried; Amanda McCabe; Julianne N P Smith; Laura M Calvi; Katherine C MacNamara
Journal:  Leukemia       Date:  2021-03-20       Impact factor: 12.883

9.  The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.

Authors:  S T Ward; K K Li; E Hepburn; C J Weston; S M Curbishley; G M Reynolds; R K Hejmadi; R Bicknell; B Eksteen; T Ismail; A Rot; D H Adams
Journal:  Br J Cancer       Date:  2014-11-18       Impact factor: 7.640

10.  C-C Chemokine Receptor Type 5 (CCR5)-Mediated Docking of Transferred Tregs Protects Against Early Blood-Brain Barrier Disruption After Stroke.

Authors:  Peiying Li; Long Wang; Yuxi Zhou; Yu Gan; Wen Zhu; Yuguo Xia; Xiaoyan Jiang; Simon Watkins; Alberto Vazquez; Angus W Thomson; Jun Chen; Weifeng Yu; Xiaoming Hu
Journal:  J Am Heart Assoc       Date:  2017-08-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.